End-of-day quote
Shenzhen S.E.
03:30:00 26/04/2024 am IST
|
5-day change
|
1st Jan Change
|
24.81
CNY
|
+3.94%
|
|
+6.57%
|
-8.52%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
11,855
|
16,092
|
15,769
|
24,736
|
27,326
|
24,998
|
-
|
-
|
Enterprise Value (EV)
1 |
10,073
|
14,728
|
14,224
|
23,255
|
25,243
|
21,957
|
21,006
|
19,887
|
P/E ratio
|
17.6
x
|
22.2
x
|
19.8
x
|
27.6
x
|
26.3
x
|
20.3
x
|
16.2
x
|
13.6
x
|
Yield
|
0.86%
|
0.63%
|
1.28%
|
0.81%
|
1.18%
|
0.72%
|
0.85%
|
0.96%
|
Capitalization / Revenue
|
2.86
x
|
4.79
x
|
4.01
x
|
5.75
x
|
5.42
x
|
4.19
x
|
3.48
x
|
2.94
x
|
EV / Revenue
|
2.43
x
|
4.38
x
|
3.61
x
|
5.41
x
|
5.01
x
|
3.68
x
|
2.93
x
|
2.34
x
|
EV / EBITDA
|
11.7
x
|
15.4
x
|
13.7
x
|
20.5
x
|
19
x
|
15.2
x
|
11.6
x
|
9.12
x
|
EV / FCF
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
3.28
x
|
3.92
x
|
3.2
x
|
4.4
x
|
4.25
x
|
3.4
x
|
2.86
x
|
2.47
x
|
Nbr of stocks (in thousands)
|
10,19,388
|
10,07,663
|
10,07,588
|
10,07,588
|
10,07,588
|
10,07,588
|
-
|
-
|
Reference price
2 |
11.63
|
15.97
|
15.65
|
24.55
|
27.12
|
24.81
|
24.81
|
24.81
|
Announcement Date
|
26/02/20
|
26/02/21
|
25/02/22
|
27/02/23
|
29/03/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
4,149
|
3,361
|
3,936
|
4,299
|
5,042
|
5,961
|
7,178
|
8,503
|
EBITDA
1 |
860.8
|
955.5
|
1,041
|
1,132
|
1,328
|
1,447
|
1,812
|
2,180
|
EBIT
1 |
770.8
|
856.2
|
925.9
|
1,003
|
1,182
|
1,385
|
1,744
|
2,080
|
Operating Margin
|
18.58%
|
25.47%
|
23.53%
|
23.34%
|
23.45%
|
23.23%
|
24.29%
|
24.46%
|
Earnings before Tax (EBT)
1 |
767.1
|
850.5
|
915.8
|
989.9
|
1,169
|
1,390
|
1,733
|
2,066
|
Net income
1 |
663.3
|
728.3
|
797.8
|
900.9
|
1,037
|
1,234
|
1,542
|
1,835
|
Net margin
|
15.99%
|
21.67%
|
20.27%
|
20.96%
|
20.57%
|
20.71%
|
21.48%
|
21.58%
|
EPS
2 |
0.6600
|
0.7200
|
0.7900
|
0.8900
|
1.030
|
1.225
|
1.530
|
1.824
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
0.1000
|
0.1000
|
0.2000
|
0.2000
|
0.3200
|
0.1788
|
0.2114
|
0.2387
|
Announcement Date
|
26/02/20
|
26/02/21
|
25/02/22
|
27/02/23
|
29/03/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
1,044
|
992.6
|
1,009
|
1,119
|
1,178
|
1,179
|
1,222
|
1,256
|
1,386
|
1,358
|
1,389
|
1,457
|
1,647
|
1,613
|
1,715
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
145.2
|
209.7
|
304.9
|
334.3
|
154.6
|
261.6
|
364.5
|
379.4
|
176.9
|
304.9
|
410.4
|
426.3
|
199.1
|
501.1
|
-
|
Operating Margin
|
13.91%
|
21.13%
|
30.24%
|
29.87%
|
13.12%
|
22.19%
|
29.84%
|
30.21%
|
12.77%
|
22.46%
|
29.54%
|
29.26%
|
12.09%
|
31.08%
|
-
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net income
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EPS
2 |
0.1200
|
0.1900
|
0.2500
|
0.3000
|
0.1500
|
0.2300
|
0.3100
|
0.3400
|
0.1500
|
0.2600
|
0.3600
|
0.3800
|
0.2200
|
0.4500
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
25/02/22
|
22/04/22
|
29/07/22
|
26/10/22
|
27/02/23
|
13/04/23
|
30/07/23
|
25/10/23
|
29/03/24
|
19/04/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
1,783
|
1,364
|
1,544
|
1,481
|
2,083
|
3,041
|
3,993
|
5,111
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
20.2%
|
18.3%
|
17.6%
|
17.2%
|
17.3%
|
17%
|
17.9%
|
18.3%
|
ROA (Net income/ Total Assets)
|
16.1%
|
16.3%
|
15.2%
|
-
|
-
|
15.3%
|
15.9%
|
15.9%
|
Assets
1 |
4,116
|
4,472
|
5,242
|
-
|
-
|
8,079
|
9,696
|
11,538
|
Book Value Per Share
2 |
3.550
|
4.080
|
4.890
|
5.580
|
6.390
|
7.300
|
8.680
|
10.00
|
Cash Flow per Share
2 |
0.3000
|
1.240
|
0.7000
|
0.8500
|
1.000
|
1.140
|
1.350
|
1.520
|
Capex
1 |
160
|
268
|
206
|
328
|
373
|
450
|
369
|
357
|
Capex / Sales
|
3.86%
|
7.99%
|
5.23%
|
7.62%
|
7.39%
|
7.56%
|
5.14%
|
4.19%
|
Announcement Date
|
26/02/20
|
26/02/21
|
25/02/22
|
27/02/23
|
29/03/24
|
-
|
-
|
-
|
Last Close Price
24.81
CNY Average target price
32.21
CNY Spread / Average Target +29.81% Consensus |
1st Jan change
|
Capi.
|
---|
| -8.52% | 3.45B | | +25.83% | 661B | | +27.00% | 566B | | -6.76% | 352B | | +20.34% | 332B | | +3.00% | 283B | | +13.09% | 231B | | +5.46% | 200B | | -9.61% | 195B | | -6.26% | 145B |
Other Pharmaceuticals
|